Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | December 1, 2001 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00027703 |
| Study Type: | Interventional |
| Intervention: | Biological: bevacizumab|Drug: cisplatin|Drug: gemcitabine hydrochloride |
| Study Design: | Allocation: Randomized|Control: Placebo Control|Masking: Double-Blind|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Chicago|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other|NIH |
| First Received: | December 7, 2001 |
| End Date: | |
| Last Updated: | September 17, 2010 |
| Last Verified: | June 1, 2005 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
